Ronald J. Ellis Jr. - Jun 6, 2023 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Strategy Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Jun 6, 2023
Transactions value $
-$87,435
Form type
4
Date filed
6/7/2023, 09:20 PM
Previous filing
Mar 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale -$43.4K -1.11K -3.36% $38.99 32.1K Jun 6, 2023 Direct F1
transaction PCRX Common Stock Sale -$44K -1.16K -3.62% $37.87 30.9K Jun 7, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.